To our knowledge, this is the greatest survival benefit, based upon hazard ratio, ever seen in a prostate cancer,” said study presenter Stephen J. Freedland, MD.

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring prostate cancer. This dual the ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

Data from the Colorado Central Cancer Registry shows Routt County had the highest rate of prostate cancer among all Colorado ...

Multiparametric MRI detects more local recurrences after prostatectomy than prostate-specific membrane antigen PET-CT, with the two showing only moderate agreement.

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, ...

The EMA’s assessment confirms the treatment matches the reference drug in quality and performance, potentially expanding ...

Understand the key factors influencing breast cancer recurrence and discover effective treatments and lifestyle changes that ...

For clinicians, bladder stones (vesical calculi) are less a disease and more a symptom of a deeper problem, usually stasis or ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.